You just read:

Biohaven Announces Orphan Drug Designation Request Granted For BHV-0223 In The Treatment Of Amyotrophic Lateral Sclerosis ("ALS")

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

08 Dec, 2016, 03:00 ET